Multiple Metabolic Benefits in One Compound The 14-week preclinical research reinforces that GlucoVantage addresses metabolic health through multiple complementary pathways in animal models: Blood Sugar Management: Fasting blood glucose reduced by 16.7% at week 13 Improved glucose tolerance (11.2% OGTT improvement) Enhanced insulin sensitivity (34% ITT improvement) Body Composition: 33.3% reduction in body weight versus high-fat diet controls Effects maintained and increased over 13 weeks No lean mass loss concerns reported Appetite and Incretin Support: GLP-1 production increased up to 165% Sustained incretin enhancement across study duration Natural appetite regulation support The Bioavailability Advantage: GlucoVantage's effectiveness at just 200mg daily stems from a fundamental advantage over standard berberine: it's already in the form your body can absorb

This amount is substantial enough to support muscle preservation and contribute meaningfully to your daily protein goals without being so large that it triggers uncomfortable fullness or digestive issues
Healthcare provider guidance: Sometimes, your provider will recommend a pause or discontinuation if health risks outweigh ongoing benefits
The Ozempic Dilemma: Rationing Amidst Rising Demand Ozempic, a product of Novo Nordisk, is at the center of an unfolding medical and supply chain conundrum
At En Vogue IV Therapy and Wellness, we offer monthly medical weight loss follow-ups to monitor progress, adjust dosing as needed, and support you throughout your journey
Clinical Corner Benefits of using CGM with GLP-1 drugs for diabetes treatment Published: Jan